{
  "docId": "019de073-bad9-7032-8a81-e4ebe475dedb",
  "docSlug": "033dbe0b064db9b5c6a8c7c8096ccb5c",
  "documentTitle": "Genprex | Investor Presentation Deck | 44 slides",
  "authorId": "genprex",
  "authorName": "Genprex",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 16,
  "pageCount": 44,
  "prevPage": 15,
  "nextPage": 17,
  "slideType": "appendix_methodology",
  "function": "plan_implementation",
  "density": "dense",
  "nDataPoints": 5,
  "notes": "The slide outlines a clinical trial methodology comparing combination therapy against monotherapy continuation.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-bad9-7032-8a81-e4ebe475dedb/16",
  "deckHref": "/decks/019de073-bad9-7032-8a81-e4ebe475dedb",
  "deckJsonHref": "/decks/019de073-bad9-7032-8a81-e4ebe475dedb.json",
  "deckAnchorHref": "/decks/019de073-bad9-7032-8a81-e4ebe475dedb#slide-16",
  "components": [
    {
      "bbox": {
        "h": 0.45,
        "w": 0.96,
        "x": 0.02,
        "y": 0.46
      },
      "kind": "diagram",
      "text": "Study design flow showing Phase 1 dose escalation and Phase 2 comparison of REQORSA+Tagrisso vs Tagrisso monotherapy.",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "694d1e4c-05d9-4691-b6e5-a909633f3c67",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.45,
        "x": 0.03,
        "y": 0.06
      },
      "kind": "list",
      "text": "GENERAL STUDY CHARACTERISTICS: FDA Fast Track, ~15 sites, ~92 patients, interim analysis at 25 events.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "45594bd7-cb39-42f7-8e41-e2986dcb787e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.42,
        "x": 0.53,
        "y": 0.17
      },
      "kind": "paragraph",
      "text": "REQORSA in combination with AstraZeneca's Tagrisso for NSCLC",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d9b04053-8356-4813-a8af-d6b11403a8ae",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.72,
        "x": 0.13,
        "y": 0.94
      },
      "kind": "source-note",
      "text": "Continuing Osimertinib (Tagrisso) Treatment After Progression Prolongs Survival Benefit in NSCLC. Targeted Oncology. Accessed November 10, 2020.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b2a9a8b9-70e2-43fc-bf33-cf96995f65c5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.35,
        "x": 0.56,
        "y": 0.08
      },
      "kind": "title",
      "text": "Acclaim-1",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "23df3ebd-8044-4135-9a8b-a689db9ebda9",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "clinical-trial-design",
      "slug": null,
      "matchId": "c001a2a3-706c-402a-9559-57e44c998174",
      "evidence": "Visual representation of study arms and progression milestones",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 20,
      "from": 9,
      "beatId": "727dc990-5781-44c1-9860-17b14bcb030f",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Satisfaction",
      "beatSlug": "monroes-sequence-satisfaction",
      "evidence": "Slides 9-20: Solution and traction for REQORSA therapy",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}